Megacable Holdings, S. A. B. de C. V. (MHSDF)

Theseus Pharmaceuticals Balance Sheet

Financials in millions MXN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,085	4,228	1,539	1,384	3,696	4,260
Cash & Short-Term Investments	3,085	4,228	1,539	1,384	3,696	4,260
Cash Growth	-32.94%	174.73%	11.15%	-62.55%	-13.22%	92.74%
Accounts Receivable	1,903	2,194	1,970	2,134	1,571	1,440
Other Receivables	2,143	1,623	1,665	1,715	1,671	1,046
Receivables	4,046	3,817	3,636	3,848	3,242	2,486
Inventory	603.81	633.01	768.37	652.58	430.81	435.54
Other Current Assets	1,153	1,045	1,111	680.01	346.58	251.58
Total Current Assets	8,887	9,723	7,053	6,565	7,716	7,432
Property, Plant & Equipment	56,200	56,418	54,253	47,156	39,302	34,132
Long-Term Investments	-	1.8	1.8	-	-	492.33
Goodwill	4,366	4,366	4,366	4,378	4,378	4,378
Other Intangible Assets	1,415	3.04	5.87	50.07	49.87	106.3
Long-Term Accounts Receivable	-	-	509.33	119.16	-	-
Other Long-Term Assets	75.54	1,445	1,131	1,343	1,422	2,237
Total Assets	72,330	73,282	68,484	60,608	53,785	49,757
Accounts Payable	4,490	3,331	3,341	4,167	5,222	3,241
Accrued Expenses	466.31	471.16	410.95	245.51	216.48	159.22
Short-Term Debt	1,614	-	62.36	-	-	-
Current Portion of Long-Term Debt	283.7	292.17	5,538	3,286	2,918	0.46
Current Portion of Leases	303.84	1,453	264.93	285.85	1,760	1,391
Current Income Taxes Payable	-	-	-	-	-	42.09
Current Unearned Revenue	254.17	287.56	334.71	266.37	328.83	149.23
Other Current Liabilities	-	1,463	1,522	806.78	778.55	814.41
Total Current Liabilities	7,412	7,297	11,474	9,058	11,223	5,798
Long-Term Debt	23,782	23,777	15,332	10,449	3,458	6,359
Long-Term Leases	1,461	1,615	1,423	1,290	840.76	960.6
Long-Term Unearned Revenue	-	560.86	618.82	685.58	658.91	603.42
Long-Term Deferred Tax Liabilities	4,282	3,933	3,394	2,646	2,373	1,956
Other Long-Term Liabilities	558.85	-	-	-	-	-
Total Liabilities	37,955	37,625	32,629	24,427	18,777	15,880
Common Stock	910.24	910.24	910.24	910.24	910.24	910.24
Additional Paid-In Capital	2,118	2,118	2,118	2,118	2,118	2,118
Retained Earnings	29,850	31,238	31,596	31,424	30,369	29,168
Comprehensive Income & Other	374.46	374.42	380.42	241.91	150.07	288.69
Total Common Equity	33,252	34,641	35,004	34,694	33,547	32,484
Minority Interest	1,123	1,016	850.94	1,488	1,460	1,393
Shareholders' Equity	34,375	35,657	35,855	36,182	35,008	33,877
Total Liabilities & Equity	72,330	73,282	68,484	60,608	53,785	49,757
Total Debt	27,445	27,136	22,621	15,310	8,977	8,711
Net Cash (Debt)	-24,360	-22,909	-21,082	-13,926	-5,280	-4,452
Net Cash Per Share	-28.40	-26.62	-24.49	-16.18	-6.14	-5.17
Filing Date Shares Outstanding	858.4	858.5	858.5	857.62	857.48	860.04
Total Common Shares Outstanding	858.4	858.5	858.5	857.62	857.48	860.04
Working Capital	1,475	2,426	-4,421	-2,492	-3,507	1,635
Book Value Per Share	38.74	40.35	40.77	40.45	39.12	37.77
Tangible Book Value	27,471	30,271	30,632	30,266	29,119	27,999
Tangible Book Value Per Share	32.00	35.26	35.68	35.29	33.96	32.56
Land	-	438.61	399.94	292.35	167.09	148.38
Buildings	-	411.56	405.91	386.37	371.8	342.38
Machinery	-	92,968	88,881	75,014	61,882	52,739
Construction In Progress	-	4,249	3,082	3,745	3,144	3,112
Leasehold Improvements	-	934.25	-	695.54	587.27	518.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.